Ozempic reduced mean HbA1c by 1.7%, while liraglutide showed a difference of only 1%
Fumagalli, M., Lecca, D., Abbracchio, M
Transcutaneous auricular VNS (taVNS) via the ear vagus nerve stimulator have shown improved glucose tolerance (from 9.7 mmol/L to 7.5 mmol/L) in T2DM patients (Huang et al
According to Lake, participants also experienced an average weight loss of around 17 pounds in the 24 weeks, with significant improvements in glucose, insulin resistance and triglyceride levels
How to Tell If a GLP-1 Provider Is Cutting Corners Red Flags: No lab requirement before prescribing Instant approval without medical history review One-size-fits-all dosing plans No follow-up or monitoring protocol Limited or no access to a licensed clinician Patients should feel empowered to ask: What data are you using to determine this is safe for me? Patient Scenarios: Real-World Context Case 1: Undiagnosed Prediabetes A patient begins semaglutide without labs
M.SpitzD